Skip to main content

Life Sciences & Medical Technology

Empowering Successful Results

State and federal regulatory initiatives present unique challenges to life sciences companies big and small. As companies look to grow their businesses and enter new fields, we bring our diverse and deep understanding of the regulatory process to support clients in making sound decisions. We have extensive experience dealing with these issues and have positioned ourselves to be effective by developing relationships with key policymakers and industry stakeholders, ensuring your needs and concerns are heard. 

Share
 

Our Experience

Case Study
On behalf of Karl Storz Endoscopy, ML Strategies has advocated for uniform federal regulation to protect patient safety before the FDA and with members of Congress — and defeated the digital right to repair from being implemented in Massachusetts.
Case Study
ML Strategies' work with a coalition of drug manufacturers and patient advocates on Johnson & Johnson’s behalf helped secure the passage of Massachusetts legislation that allows consumers to use drug manufacturers' life-saving prescription discount programs.

Service Areas

Our Approach

Our bipartisan team includes individuals with regulatory and legislative backgrounds, bringing an unparalleled perspective to addressing your needs. ML Strategies —at both the state and federal level — excels at elevating client issues before policymakers, the executive branch, and relevant agencies like the Food & Drug Administration (FDA) or the Centers for Medicare & Medicaid Services (CMS). ML Strategies is capable of handling a client’s diverse set of needs as it navigates the evolving regulatory landscape.

Life Sciences & Medical Technology Policy Areas
  • Medical devices & equipment
  • Pharmaceuticals
  • Electronic health records & software
  • Diagnostic equipment
  • Regulatory compliance
Key Experience
  • Former Health Policy Director for the Senate Committee on Finance
  • Former Member of Congress, State of New Hampshire
  • Former Chief Counsel to a member of the Senate Commerce and Finance committees
  • Former Massachusetts Governor
  • Former Senior Policy Advisor at the US Food and Drug Administration in the Center for Drug Evaluation and Research

Meet ML Strategies